Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9‐year experience in a tertiary care paediatric hospital setting
- 13 October 2019
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 50 (1) , 61-73
Abstract
Background: Severe cutaneous adverse reactions (SCARs) are delayed‐type hypersensitivity reactions to drugs including as follows: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Stevens‐Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN) and Acute Generalized Exanthematous Pustulosis (AGEP). Incidence, triggers and management of SCARs have not been investigated in large‐scale epidemiological studies on children.Objective: The aim of our study was to collect epidemiological, clinical and aetiological data from children with SCARs referred to our tertiary care paediatric hospital of Florence.Methods: From 2010 to 2018 charts of children with diagnosis of SCAR were reviewed, and data collected during the acute phase and/or the subsequent allergy evaluation. Patients underwent patch tests, intradermal tests and lymphocyte transformation tests. All children were investigated for infectious diseases.Results: Incidence of SCARs in hospitalized children was 0.32% over a 9‐year period. Fifty‐four children were enrolled (31 M; 23 F; median age 6.5 years): 17 cases of DRESS, 30 SJS, 3 TEN, 2 AGEP, 1 linear immunoglobulin A bullous disease (LABD) and 1 pemphigus. Twenty‐eight out of 54 patients underwent drug allergy investigations, and 50% of them resulted positive. Combining clinical history and results of allergy work‐up, 74% SCARs seem to be caused by drugs, 18.6% by both drugs and infections, 3.7% by infections, and 3.7% remained idiopathic. No deaths occurred.Conclusions: In this study, SCARs incidence is in line with literature data. Drugs were most commonly the leading cause. Management of SCARs requires cooperation among professional figures for an early diagnosis and a prompt treatment. Mortality rate seems to be lower in children.Keywords
This publication has 72 references indexed in Scilit:
- Cutaneous adverse drug reaction profile in a tertiary care out patient setting in Eastern IndiaIndian Journal of Pharmacology, 2012
- Adverse cutaneous drug reactions among hospitalized patients: five year surveillanceCutaneous and Ocular Toxicology, 2012
- Drug eruptions: An 8-year study including 106 inpatients at a dermatology clinic in TurkeyIndian Journal of Dermatology, 2012
- Severe adverse cutaneous drug eruptions: epidemiological and clinical featuresInternational Journal of Dermatology, 2011
- Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: A multicentric retrospective studyJournal of Postgraduate Medicine, 2011
- Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspectiveInternational Journal of Applied & Basic Medical Research, 2011
- Retrospective Analysis of 32 Pediatric Patients with Anticonvulsant Hypersensitivity Syndrome (ACHSS)Pediatric Dermatology, 2009
- Epidemiological study of severe cutaneous adverse drug reactions in a city district of ChinaClinical and Experimental Dermatology, 2006
- Cutaneous adverse drug reactions: a 9-year study from a South Indian HospitalPharmacoepidemiology and Drug Safety, 2005
- Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in ChildrenDrug Safety, 2002